bizpeel · Business report · KlarovelReport v2 · data as of 2026-10-22
Klarovel
klarovel.com
How does a solo-built peptide protocol tool find users, and why is its revenue falling?
Product at a glance
- What it is
- A web tool that takes a health questionnaire and optional lab results, lets a rules engine choose peptides, doses and cycles, and produces a 12-week protocol with tracking.
- Who it is for
- Self-directed athletes, biohackers and longevity seekers researching peptides on their own.
- How it charges
- No subscription, you buy per protocol: $99 / protocol, paid once and covering 12 weeks; the next cycle is another $99 bought only when needed, with no auto-renewal. It sells the plan, never the peptides.
- Business model
- A pay-per-report digital product: dosage guides and free calculators bring traffic, and each protocol sold is a one-off payment.
Revenue, last 12 months
$18.4K
All-time $319K, mostly earlier
Revenue, last 30 days
$330
−55% on the prior 30 days
MRR
—
Shown as “-” on 公开收入数据: no active subscriptions · now $99 one-time
Best month
$4,331
December 2025 · September 2026 was $466
Revenue as of 2026-10-27 (public channels, daily)Report as of 2026-10-2201
Subscribe to read the full report
6 chapters, with every figure, post and source.
- ?Where does its traffic come from?
- ?Which content carries the traffic, and how well does it rank?
- ?When did revenue peak, and how does that relate to the launch?
- 01Product overview
- 02Marketing map
- 03The growth plays
- 04How it uses social
- 05Timeline
- 06What to take from it
Subscribe to read the complete research
5 chapters locked · a subscription opens every report